VERICEL (ATQP MU) stock market data APIs
€28.4783
0(0%)
as of March 13, 2026
Try our APIs with
free plan!
VERICEL Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for ATQP.MU.
Prev. Close
28.4783
Open
28.4783
High
28.4783
Low
28.4783
52 wk Range
25.8-43.4
Market Cap
1 572 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get VERICEL data using free add-ons & libraries
Get VERICEL Fundamental Data
VERICEL Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-02-26
- EPS/Forecast: 0.38
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
VERICEL News
New
What Makes Vericel Corporation (VCEL) an Investment Bet?
Madison Investments, an investment advisor, released its fourth-quarter 2025 investor letter for “Madison Small Cap Fund”. A copy of the letter can be downloaded here. The fourth quarter was chal...
Will FDA Approval of Burlington MACI Manufacturing Shift Vericel's (VCEL) Long-Term Growth Narrative
In early March 2026, Vericel Corporation reported that the FDA approved commercial manufacturing of its knee cartilage repair therapy MACI at the company’s Burlington, Massachusetts cell therapy fac...
FDA MACI Approval Tests Vericel’s Capacity Plans And Growth Story
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Vericel received FDA approval for commercial manufacturing of MACI at its new B...
Vericel Corporation (VCEL) Secures FDA Approval for Commercial Manufacturing of MACI
Vericel Corporation (NASDAQ:VCEL) is one of the Best Small-Cap Growth Stocks to Buy According to Hedge Funds. On March 4, Vericel Corporation (NASDAQ:VCEL) announced securing a major win from the FDA....
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
